Beijing Bohui Innovation Biotechnology Group Co., Ltd. (SHE:300318)

China flag China · Delayed Price · Currency is CNY
5.67
-0.24 (-4.06%)
May 12, 2026, 3:04 PM CST
Market Cap4.63B -11.4%
Revenue (ttm)812.78M +2.7%
Net Income-95.15M
EPS-0.12
Shares Out816.90M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume13,944,284
Average Volume8,805,551
Open5.56
Previous Close5.91
Day's Range5.56 - 5.91
52-Week Range5.29 - 8.63
Beta-0.05
RSI46.71
Earnings DateApr 25, 2026

About SHE:300318

Beijing Bohui Innovation Biotechnology Group Co., Ltd. engages in the research and development, production, sale, and after-sale service of diagnostic products in China. The company offers human immunoglobulin for rabies, tetanus, hepatitis B, and intravenous injections; albumin; human prothrombin complex; and vaccine for rabies. It also provides molecular platform, such as Automatic Real-time Fluorescent Nucleic Acid Cartridge Analyzer(BHQ-III), and GenPlex BHF-VI Nucleic Acid Chip Analyzer; Trace Element Analyzers; Fluorescence Immunoassay An... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2001
Employees 2,179
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300318
Full Company Profile

Financial Performance

Financial Statements